Literature DB >> 20403852

Quality-of-life assessment after primary and revision ear surgery using the chronic ear survey.

Kyu Hwan Jung1, Yang-Sun Cho, Sung Hwa Hong, Won-Ho Chung, Gil Joon Lee, Sang Duk Hong.   

Abstract

OBJECTIVE: To measure subjective outcomes after primary and revision surgery for chronic ear disease.
DESIGN: Prospective questionnaire-based outcome study.
SETTING: Tertiary referral center. PATIENTS: Adults with chronic otitis media with or without cholesteatoma.
INTERVENTIONS: Primary or revision surgery for chronic ear disease. MAIN OUTCOME MEASURES: The Chronic Ear Survey, a disease-specific outcome survey, was administered preoperatively and at 1 year after surgery. We analyzed the total score and the activity restriction, symptom, and medical resource utilization subscale scores. Scores were averaged on the basis of the number of questions included in each category. Differences in preoperative and postoperative scores were analyzed within and between the 2 groups. We also assessed audiometry, postoperative complications, and the clinical condition of the operated-on ear.
RESULTS: Twenty-one patients were enrolled in the primary surgery group, and 20 were enrolled in the revision surgery group. Significant improvements in the total score and each subscale score were observed in both groups at the 1-year postoperative survey. Improvements in the total score and symptom subscale scores were greater in the primary surgery group than in the revision surgery group (P < .05). The air conduction thresholds and any postoperative clinical problems were correlated with the total score and subscale scores in the primary group but not in the revision surgery group.
CONCLUSION: Comparable objective outcomes are achieved after primary and revision surgery for chronic ear disease, but the improvement in quality of life is greater in the primary surgery group.

Entities:  

Mesh:

Year:  2010        PMID: 20403852     DOI: 10.1001/archoto.2010.24

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  7 in total

Review 1.  [State of the art of quality-of-life measurement in patients with chronic otitis media and conductive hearing loss].

Authors:  S Lailach; I Baumann; T Zahnert; M Neudert
Journal:  HNO       Date:  2018-08       Impact factor: 1.284

2.  Health-related quality of life measurement after cholesteatoma surgery: comparison of three different surgical techniques.

Authors:  Susen Lailach; Max Kemper; Nikoloz Lasurashvili; Thomas Beleites; Thomas Zahnert; Marcus Neudert
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-31       Impact factor: 2.503

3.  Mental health and quality of life in patients with chronic otitis media.

Authors:  Salih Bakir; Vefa Kinis; Yasin Bez; Ramazan Gun; Ediz Yorgancilar; Musa Ozbay; Bülent Aguloglu; Faruk Meric
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-08       Impact factor: 2.503

4.  Disease-specific quality of life and psychological distress after endoscopic tympanoplasty.

Authors:  Daniela Lucidi; Marella Reale; Matteo Fermi; Edoardo Bassano; Marco Bonali; Ignacio Javier Fernandez; Livio Presutti; Matteo Alicandri-Ciufelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-16       Impact factor: 2.503

5.  The Impact of Childhood Acute Otitis Media on Parental Quality of Life in a Prospective Observational Cohort Study.

Authors:  Katsiaryna Holl; Mats Rosenlund; Carlo Giaquinto; Sven-Arne Silfverdal; Alfonso Carmona; James Larcombe; José Garcia-Sicilia; Ahmet Fuat; Maria Eulalia Muñoz; María Luisa Arroba; Brigitte Sloesen; Jens Vollmar; Jean-Yves Pirçon; Johannes G Liese
Journal:  Clin Drug Investig       Date:  2015-10       Impact factor: 2.859

6.  Mastoidectomy and mastoid obliteration with autologous bone graft: a quality of life study.

Authors:  George Kurien; Kate Greeff; Nahla Gomaa; Allan Ho
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-09-23

7.  The evaluation of canal wall up cholesteatoma surgery with the Glasgow Benefit Inventory.

Authors:  Johanna Westerberg; Elina Mäki-Torkko; Henrik Harder
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-04       Impact factor: 2.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.